Edwards Lifesciences (EW) EBIT Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) EBIT Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.63 Bn | 109.41 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 72.75 Bn | 72.21 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | 16.18% |
| 10 | Zimmer Biomet Holdings | 19.10 Bn | 18.69 Bn | 1.54 Bn | 8.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.81% |
| Mar 31, 2026 | 20.97% |
| Dec 31, 2025 | -51.66% |
| Sep 30, 2025 | -12.41% |
| Jun 30, 2025 | 12.20% |
| Mar 31, 2025 | 13.12% |
| Dec 31, 2024 | -9.86% |
| Sep 30, 2024 | -4.18% |
| Jun 30, 2024 | 39.09% |
| Mar 31, 2024 | -10.14% |
| Dec 31, 2023 | 75.42% |
| Sep 30, 2023 | -9.07% |
| Jun 30, 2023 | -42.66% |
| Mar 31, 2023 | -11.49% |
| Dec 31, 2022 | -47.20% |
| Sep 30, 2022 | 3.10% |
| Jun 30, 2022 | -15.24% |
| Mar 31, 2022 | 14.42% |
| Dec 31, 2021 | 6.55% |
| Sep 30, 2021 | 9.08% |